The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
Open accessAbstract
It has been suspected that the increased sympathetic activity seen in patients with chronic congestive heart failure from dilated cardiomyopathy may be harmful. We therefore tested the long-term effect of metoprolol on eight patients in a double-blind, randomized protocol and 12 patients in an unblinded, crossover protocol who were treated for 12 months (range 10 to 24), and compared them with 16 similar subjects who were treated with placebo for 10 months (range 6 to 12) in a double-blind, randomized protocol. Patients were followed by serial clinical assessment, treadmill testing, radionuclide ventriculography, and echocardiography. Metoprolol-treated patients had an improvement in mean exercise capacity by 3 mets (p less than .0001) while experiencing a significant improvement in functional classification (p less than .001) during both the double-blind and open-label crossover studies and had an improved ejection fraction during the double-blind study (p less than .02). These improvements were not seen in matched control subjects receiving placebo. Seven of 20 patients receiving long-term metoprolol therapy had resolution of nearly all symptoms of heart failure, doubled their exercise capacity, and had progressive improvement in resting radionuclide left ventricular ejection fraction (12.6 +/- 3% to 26.9 +/- 6%) and echocardiographic left ventricular end-diastolic dimension (7.7 +/- 0.5 to 6.5 +/- 0.5 cm). Only one of 21 patients treated was intolerant of metoprolol. We conclude that metoprolol can be given safely to a select group of patients with dilated cardiomyopathy in doses that substantially reduce both resting and exercise heart rates. Long-term beta-blockade improved functional class and exercise capacity in 14 of 20 patients while producing an exceptional clinical response in seven that was accompanied by improved resting parameters of left ventricular function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Bruce, R. A., Kusumi, F., & Hosmer, D. (1973) · American Heart Journal · doi:10.1016/0002-8703(73)90502-4 · Cited by 2,049
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 920
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
Waagstein, F., Hjalmarson, A., Varnauskas, E., & Wallentin, I. (1975) · Heart · doi:10.1136/hrt.37.10.1022 · Cited by 832
Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.
(1980) · Heart · doi:10.1136/hrt.44.6.672 · Cited by 760
The Neurohumoral Axis in Congestive Heart Failure
FRANCIS, G. S., GOLDSMITH, S. R., LEVINE, T. B., OLIVARI, M. T., & COHN, J. N. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-370 · Cited by 600
Physical activity and the prevention of coronary heart disease
Fox, S. M., & Naughton, J. P. (1972) · Preventive Medicine · doi:10.1016/0091-7435(72)90079-5 · Cited by 497
Wilson, J. R., Martin, J. L., Schwartz, D., & Ferraro, N. (1984) · Circulation · doi:10.1161/01.cir.69.6.1079 · Cited by 452
Chidsey, C. A., Harrison, D. C., & Braunwald, E. (1962) · New England Journal of Medicine · doi:10.1056/nejm196209272671305 · Cited by 436
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.
Swedberg, K., Hjalmarson, A., Waagstein, F., & Wallentin, I. (1980) · Heart · doi:10.1136/hrt.44.2.117 · Cited by 318
Cited by
Guidelines for the diagnosis and treatment of chronic heart failure
Remme, W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2783 · Cited by 1,592
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, A., Swedberg, K., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,234
Packer, M. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90167-l · Cited by 1,056
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., Navarrete, E. G., Hu, S., Wang, L., Lee, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003552 · Cited by 696
COMMITTEE MEMBERS, WILLIAMS, J. F., BRISTOW, M. R., FOWLER, M. B., FRANCIS, G. S., GARSON, A., GERSH, B. J., HAMMER, D. F., HLATKY, M. A., LEIER, C. V., et al. (1995) · Circulation · doi:10.1161/01.cir.92.9.2764 · Cited by 663
Metadata
- Authors
- Engelmeier, R. S., O'Connell, J. B., Walsh, R., Rad, N., Scanlon, P. J., & Gunnar, R. M.
- Venue
- Circulation
- Published
- 1985-09
- Volume
- 72
- Issue
- 3
- Pages
- 536-546
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2071833353
- Cited by
- 439
- References
- 15
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. https://app.cochat.ai/papers/10.1161/01.cir.72.3.536
- The paper
- Engelmeier, R. S., O'Connell, J. B., Walsh, R., Rad, N., Scanlon, P. J., & Gunnar, R. M. (1985). Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation. https://doi.org/10.1161/01.cir.72.3.536
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.